FROM MOLECULES TO THE CLINIC: LINKING SCHIZOPHRENIA AND METABOLIC SYNDROME THROUGH SPHINGOLIPIDS METABOLISM

FROM MOLECULES TO THE CLINIC: LINKING SCHIZOPHRENIA AND METABOLIC SYNDROME THROUGH SPHINGOLIPIDS METABOLISM

Metabolic syndrome (MS) is a prevalent and severe comorbidity observed in schizophrenia (SZ). The exact nature of this association is controversial and very often accredited to the effects of psychotropic medications and disease-induced life-style modifications, such as inactive lifestyle, poor diet...

Full description

Bibliographic Details
Main Authors: Rolando I Castillo, Leonel E Rojo, Marcela Henriquez-Henriquez, Hernan Silva, Alejandro Maturana, Maria J Villar, Manuel Fuentes, Pablo A. Gaspar
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-11-01
Series:Frontiers in Neuroscience
Subjects:
Schizophrenia
Sphingolipids
psychosis
metabolic syndrome
Antisychotic drugs
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00488/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00488/full

Similar Items